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836Background: The edge-to-edge technique has been proposed to prevent systolic anterior motion (SAM) of the
mitral valve. There is limited clinical data available on outcomes of this technique for this indication. We re-
viewed the midterm results of this technique for SAM prevention and treatment.
Methods:A total of 2226 patients had mitral valve repair between 2000 and 2011, 1148 of which were for myx-
omatous mitral regurgitation. Beginning in 2000, predictability of postrepair SAM based on the prebypass, intra-
operative transesophageal echocardiogram arose in our program. The edge-to-edge technique was used in 65
patients (5.7%) for SAM management, in 53 patients preemptively for transesophageal echocardiogram-
based SAM prediction, and in 12 patients for postrepair SAM treatment.
Results: There was no operative mortality. Postoperative mitral regurgitation was significantly improved in all
patients compared with the preoperative grade (P<.001). SAM was completely eliminated, the mean mitral
regurgitation grade in the postoperative period was 0.7  0.9, and the mean transmitral gradient was 1.3 
2.2 mm Hg. During a mean follow-up of 26 months, 1 patient in the SAM treatment group presented late recur-
rence of SAM and no patients developed mitral stenosis (mean transmitral gradient, 2.0 2.6 mm Hg; P¼ .12).
Without SAM prediction and preemptive edge-to-edge technique, the expected rate of SAM would have been
5.7%; however, the observed rate was 1% (12 of 1148 patients).
Conclusions: Initiating an expectation for prebypass SAM prediction, combined with a surgical SAM preven-
tion strategy, resulted in a reduced prevalence of SAM compared with our model of observed to-expected-ratios
and to published norms. (J Thorac Cardiovasc Surg 2013;146:836-40)In mitral valve (MV) repair for myxomatous prolapsed
valves, there is the potential for creating systolic anterior
motion (SAM) of the anterior mitral leaflet and consequent
obstruction of the left ventricular outflow tract (LVOT),
which can add significant morbidity and the need for a sec-
ond exposure to cardiopulmonary bypass (CPB).1,2
Although the standard MV repair techniques, including
quadrangular resection and sliding plasty to reduce the
height of the posterior leaflet and ring annuloplasty, are usu-
ally sufficient to eliminate regurgitation and minimize the
risk of SAM, it can still occur after repair. We previously re-
ported our initial experience in using the edge-to-edge
(E2E) technique in preventing SAM in patients at high
risk based on prebypass pre-MV repair echocardiographic
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The Journal of Thoracic and Cardiovascular Surgthis experience, during 2000 we initiated an expectation
that intraoperative, prebypass transesophageal echocardi-
ography (TEE) examinations would include a SAM predic-
tion, which if repaired would lead to a very low prevalence
of postrepair SAM.
This report expands on a previous study focusing on our
early and medium-term experience with the E2E technique
in MV repair in patients at high risk of SAM based on
known preoperative assessment of SAM potential, or
SAM after MV repair.
METHODS
Study Design
This study is a retrospective review of all patients who underwent sur-
gical MV repair between 2000 and 2011 at our institution, in whom E2E
was used to manage SAM. The study was approved by the Brigham and
Women’s Hospital Institutional Review Board, and patient consent was
waived.
The primary outcome measure was the recurrence of SAM. Secondary
outcomes were development of mitral stenosis, the need for MV reopera-
tion, or significant mitral regurgitation.
Surgical Technique
All patients undergoingMV repair had intraoperative pre-CPB TEE and
the MV was evaluated for anatomic causes of mitral regurgitation and the
potential to develop SAM after the repair. The operative approach to MV
repair was through amedian sternotomy, whichwas limited to a lower hem-
isternotomy in isolated MV repairs, and through the left atrium after estab-
lishing CPB. The valve was inspected intraoperatively to confirm theery c October 2013
Abbreviations and Acronyms
A2 ¼ middle scallop of the anterior mitral leaflet
CPB ¼ cardiopulmonary bypass
E2E ¼ edge-to-edge
LVOT ¼ left ventricular outflow tract
MV ¼ mitral valve
SAM ¼ systolic anterior motion
TEE ¼ transesophageal echocardiography
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Dechocardiographic findings and to identify any additional lesions. Avariety
of techniques were used to achieve a competent MV before using the E2E
to manage SAM. A majority of patients underwent a posterior leaflet qua-
drangular resection with a modified sliding annuloplasty or folding valvu-
loplasty of a prolapsing posterior leaflet.4 All but 1 patient received
a prosthetic annuloplasty ring. The E2E repair was used in 2 principal cir-
cumstances to manage SAM: to prevent SAM in patients deemed at high
risk of developing SAM after MV repair, based on intraoperative prerepair
TEE assessment of the mitral valve before CPB was instituted, and to treat
SAM in patients in whom SAM was identified by TEE after initial termi-
nation of CPB after MV repair. The E2E stitch was placed to prevent SAM
of the anterior mitral leaflet in the LVOT at the coaptation point of middle
scallop of the anterior mitral leaflet (A2) andmiddle scallop of the posterior
mitral leaflet. Mitral valve calipers were used to ensure that each of the 2
residual orifice areas was>2 cm2, as described previously.3 The E2E stitch
was a 2-0 multifilament suture placed in a figure of 8 suture mode from an-
terior to posterior leaflet.
Patients who had SAM after MV repair that was not satisfactorily re-
sponsive to the usual medical maneuvers (ie, volume resuscitation, beta
blockade, and avoiding inotropes) were managed surgically by a second
bypass run and placement of an E2E stitch.
Prediction of SAM Potential
The MV was determined to have SAM potential based on both preoper-
ative TEE exam and surgical assessment upon direct inspection. Diagnostic
elements contributing to the prediction of SAM consisted of 1 or more of
the following: the presence of SAM in the prebypass period; interaction be-
tween the anterior leaflet and the subvalvular apparatus using the Maslow
semiquantitative estimation of SAM potential5 (coaptation-septal distance
25 mm increases risk of SAM); asymmetry of the anterior leaflet, in
which the anterolateral portion of A2 is larger than the posteromedial A2
(this measurement was reported previously.3 Asymmetry measured on
TEE was validated by direct surgical measurement of anterior leaflet
lengths using a modified MV sizer [see Figure 1]. Asymmetry [lateral
A2 height minus medial A2 height 5 mm] led to prediction of
moderate-to-high risk of SAMwith risk proportional to the degree of asym-
metry); insertion location of A2 secondary chords, also reported previ-
ously3; and degree of override of the mitral annulus over the LVOT
(override of A2 over LVOT>20% increases SAM risk in proportion to per-
centage override. Percentage override and the aorto/mitral angle measure-
ment assess the same anatomical condition).
The cardiac anesthesiologist reported a high, moderate, or low potential
for SAM to the surgeon before initiation of CPB. Criteria used for com-
bined TEE and surgical assessment of significant SAM potential are sum-
marized in Table 1. In addition to optimizing the height of middle scallop of
the posterior mitral leaflet and sizing the annuloplasty band based on the
height of the A2 segment from annulus to leaflet edge, surgical modifica-
tions mitigating high SAM risk included midline or offset E2E suture
(Figure 2). E2E offset was guided by TEE and/or surgical evidence of
A2 asymmetry.The Journal of Thoracic and CaStatistical Analysis
Statistical analyses were performed with SPSS software (2010, version
19; SPSS Inc, Chicago, Ill). Data are presented as mean  standard devia-
tion. Continuous variables were analyzed with the Student t test, or the re-
lated samples Wilcoxon signed rank test when appropriate, and categorical
variables using the c2 test or the Fisher exact test when appropriate. Actu-
arial estimates were calculated using the Kaplan-Meier method and differ-
ences between curves assessed by the log-rank test. The prevalence of E2E
used for prevention or treatment SAM in the entire cohort of myxomatous
MV repairs was considered as the expected rate of SAM; the prevalence of
E2E used for SAM treatment in the same cohort of patients was considered
as the observed rate of intraoperative SAM; finally, the prevalence of E2E
for SAM treatment or late development of SAM was used as the observed
rate of overall SAM. Differences between expected and observed rates of
SAM were compared using the Fisher exact test. All statistical tests were
2-tailed.
RESULTS
Patient Characteristics
A total of 2226 patients had MV repair between October
2000 and July 2011 at our institution, 1148 of which were
for myxomatous mitral regurgitation. The E2E stitch was
used in 65 patients (5.7%) for SAM management, in 53 pa-
tients for prevention of postrepair high risk of SAM, and in
12 patients for postrepair SAM treatment. Mean age at re-
pair was 57  11 years and 36 (55.4%) were men. The
mean New York Heart Association Functional Class at ad-
mission was 1.8  0.8, and mean left ventricular ejection
fraction was 61%  11%. Patient baseline characteristics
are summarized in Table 2. Based on our SAM prediction
algorithm, the expected rate of SAM was estimated at
5.7% (65 of 1148 patients). With implementation of pre-
byass SAM prediction combined with surgical SAM pre-
vention, the observed rate of intraoperative SAM was
reduced to 1% (12 of 1148) (P<.0001).
Operative Characteristics
Operative details are summarized in Table 3. All but 1 pa-
tient had ring annuloplasty (98.5%), mostly with the
Cosgrove-Edwards band (Edwards Lifesciences LLC, Ir-
vine, Calif). The mean ring size was 36.1  2.2 mm, 2.7
mm larger in the SAM prevention group compared with
the SAM treatment group (P<.001). Not surprisingly, pa-
tients in the SAM treatment group had longer CPB and aor-
tic cross-clamp times, by 33 and 19 minutes, respectively
(P ¼ .005 and P ¼ .02, respectively), due to the second
bypass run after MV repair to correct SAM.
Outcomes
There was no operative mortality in either E2E groups,
and 6 patients (0.5%) died in the overall myxomatous
MV repair cohort. Early postoperative mitral regurgitation
was significantly improved in all patients compared with
the preoperative grade, from a mean mitral regurgitation
grade of 3.9  0.3 (severe) prerepair to 0.8  0.9 (none to
trivial) (P < .001). The mean transmitral gradient wasrdiovascular Surgery c Volume 146, Number 4 837
FIGURE 1. Modified Edwards mitral sizer (Edwards Lifesciences LLC,
Irvine, Calif). This device allows for precise measurement of middle scal-
lop of the anterior mitral leaflet annulus to leaflet edge for the lateral and the
medial aspects of the anterior mitral leaflet segment. It also facilitates as-
sessment of the degree of asymmetry of anterior mitral leaflet.
FIGURE 2. Example of an offset placement of an edge-to-edge suture. It
is important to only perform this offset in the face of asymmetry of the mid-
dle scallop of the anterior mitral leaflet segment. Offset of edge-to-edge in
a symmetric anterior mitral leaflet may result in development of late mitral
regurgitation.
TABLE 2. Baseline patient characteristics
SAM prevention
(n ¼ 53)
SAM treatment
(n ¼ 12) P
Man 30 (56.6) 6 (50) .46
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Dincreased, from amean of 0.1 0.5 mmHg to 1.3 2.2 mm
Hg (P¼ .002). No patient had evidence of SAM on postop-
erative imaging.
The 12 patients who underwent a second cross-clamp
were deemed by the operating surgeon to not be at a high
risk of SAM, based on the integrated TEE and surgical as-
sessment of the valve. On review of the TEEs and records,
among these 12 patients, 1 patient had high TEE-predicted
SAM potential but was not confirmed by surgical assess-
ment; the SAM potential was not noted on the anesthesia re-
cord in the remaining 11 patients. On re-review of the TEE
images, the SAM potential was noted to be high in 9TABLE 1. Criteria for determination of significant systolic anterior
motion (SAM) potential
Assessment Criteria
TEE criteria Prerepair SAM
C-sept distance 25 mm
Anterolateral A2 height – posteromedial
A2 height 5 mm
Insertion location of A2 secondary chords
A2 override over the LVOT>20%
Surgical assessment Height of A2 from annulus to leaflet edge
using modified Edwards mitral sizer,*
including assessment of asymmetry of
lateral and medial portions of A2
After placement of annuloplasty band,
remeasurement of A2 height to determine
if>7 to 8 mm of anterior leaflet was below
the coaptation line
P2 height reducible to 10 mm
TEE, Transesophageal echocardiography; SAM, systolic anterior motion; C-sept, co-
aptation to septum; A2, middle scallop of the anterior mitral leaflet; LVOT, left ven-
tricular outflow tract; P2, middle scallop of the posterior mitral leaflet. *See Figure 2.
838 The Journal of Thoracic and Cardiovascular Surgpatients and moderate in 2 patients. It is impossible to deter-
mine retrospectively if the SAM potential was not assessed
fully in these 11 patients. The operating surgeon evaluatedAge (y) 57.3  11.6 56.3  11.6 .79
LVEF (%) 61.5  8.4 60.6  18.4 .88
NYHA Functional Class
I 22 (41.5) 4 (33.3) .80
II 21 (39.6) 6 (50) .80
III 10 (18.9) 2 (16.7) .80
Smoking history 12 (22.6) 2 (16.7) .46
Diabetes 1 (1.9) 0 (0) .81
Hypercholesterolemia 8 (15.1) 3 (25) .46
Prior stroke 1 (1.9) 0 (0) 1
Peripheral vascular disease 0 (0) 0 (0) 1
Cerebrovascular disease 1 (1.9) 0 (0) 1
Chronic lung disease
None 39 (92.9) 9 (90) .09
Mild 3 (7.1) 0 (0) .09
Moderate 0 (0) 1 (10) .09
Mitral regurgitation
Mild 0 (0) 0 (0) 1
Moderate 5 (9.4) 1 (8.3) 1
Severe 48 (90.6) 11 (91.7) 1
Systolic anterior motion 0 (0) 1 (8.3) .19
All data are presented as mean standard deviation or number (%). LVEF, Left ven-
tricular ejection fraction; NYHA, New York Heart Association; SAM, systolic anterior
motion.
ery c October 2013
TABLE 3. Operative details
SAM prevention
(n ¼ 53)
SAM treatment
(n ¼ 12) P
Ring annuloplasty 53 (100) 11 (91.7) .19
Cosgrove-Edwards* 50 (94.3) 8 (66.7) .002
Carpentier-Edwards classic* 1 (1.9) 0 (0) .002
Carpentier-Edwards Physio* 1 (1.9) 0 (0) .002
Carbomedics AnnuloFlexy 0 (0) 3 (25) .002
Medtronic Duranz 1 (1.9) 0 (0) .002
No annuloplasty 0 (0) 1 (8.3) .002
Ring size 36.7  2.0 34  1.8 <.001
Leaflet repairs
PL segment resection and
modified sliding plasty
29 (54.7) 7 (58.3) 1
PL foldoplasty 21 (39.6) 4 (33.3) .75
Commissuroplasty 13 (24.5) 1 (8.3) .44
PL cleft repair 5 (9.4) 1 (8.3) 1
AL GoreTexx neochordae 0 (0) 1 (8.3) .19
Concomitant procedures
Aortic valve replacement 11 (20.8) 3 (25) .85
Aortic valve repair 1 (1.9) 0 (0) .85
CABG 4 (7.5) 1 (8.3) 1
Tricuspid valve repair 4 (7.5) 0 (0) .58
Cardiopulmonary bypass time
(min)
123.9  33.7 156.8  31.3 .005
Aortic cross-clamp time (min) 86.1  23.1 104.8  21.9 .02
Data are presented as mean  standard deviation or number (%). SAM, Systolic an-
terior motion; PL, posterior mitral leaflet; AL, anterior mitral leaflet; CABG, coronary
artery bypass graft surgery. *Edwards Lifesciences, Irvine, Calif. ySorin Group,
Milano, Italy. zMedtronic, Minneapolis, Minn. xW.L. Gore Associates, Newark, Del.
FIGURE3. Kaplan-Meier analysis of freedom from recurrence of systolic
anterior motion (SAM) and/or mitral valve reoperation.
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Dthe valve and considered the SAM potential to be low in all
of these 12 patients and did not perform an E2E repair. If the
E2E had been used in all patients with a high SAM potential
by TEE assessment, the observed rate of SAM could have
been further reduced to 2 of 1148 (0.2%).
Late results are summarized in Table 4. During a mean
follow-up of 26.4  24.7 months (range, 1 month to 6.6
years), there were no late reoperations. One patient in the
SAM treatment group developed late SAM, and as of this
report is being managed medically. In terms of function of
theMV, 3 patients (6.7%) developedmoderate mitral regur-
gitation at late follow-up, all in the SAM prevention group.
The freedom from SAM or MV reoperation (see Figure 3)
was 100% in the SAM prevention group up to 6.6 years,
and in the SAM treatment group freedom from SAM or
MV reoperation was 100% at 1 year and 80%  18% atTABLE 4. Late results
SAM prevention
(n ¼ 53)
SAM treatment
(n ¼ 12) P
Follow-up (mo) 27.3  26.2 21.9  5.8 .46
Systolic anterior motion 0 (0) 1 (8.3) .17
Transmitral gradient (mm Hg) 2.1  2.6 1.4  0.9 .53
Moderate MR 3 (4) 0 (0) 1
Data are presented as mean  standard deviation or number (%). SAM, Systolic
anterior motion; MR, mitral regurgitation.
The Journal of Thoracic and Ca2 and 4 years (log-rank test P¼ .08). Through implementa-
tion of prebyass SAM prediction combined with surgical
SAM prevention, the observed rate of overall SAM was
reduced to 1.0% (12 of 1148) (P<.0001).DISCUSSION
Although multiple surgical techniques have been pro-
posed to prevent SAM, it remains a challenging problem af-
ter MV repair. The overall prevalence of SAM has been
reported to vary between 7% and 11%.6,7 Carpentier
introduced quadrangular resection and sliding plasty to
reduce the height of the posterior leaflet in an effort to
reduce the risk of SAM after MV repair.8 We previously de-
scribed folding valvuloplasty as a simple nonresectional
method of reducing posterior leaflet height and avoiding
SAM4; however, no formal evaluation of the incidence of
SAM in this setting has been done. Triangular resection
of the anterior leaflet has also been proposed.9
A majority of patients with postrepair SAM can be man-
aged conservatively, with beta blockade and volume resus-
citation. Factors that tend to increase the risk of SAM
include the use of triangular resection of posterior leaflet
prolapse without reducing the height of the posterior leaflet
to 15 mm or sliding plasty, use of flexible and rigid com-
plete rings that reduce the aortomitral angle, and excessive
reduction of the mitral annulus, whereas treatment of ante-
rior pathology with limited resection or neochordae tends to
decrease the prevalence of SAM.6,9,10rdiovascular Surgery c Volume 146, Number 4 839
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systematic algorithms for managing postrepair SAM, both
intraoperatively and later, with excellent results.1 In their
review of 785 MV repairs, 52 patients (6.6%) developed
SAM while admitted to a hospital, and only 6 required sur-
gical repeat repair. However, this approach proposes man-
agement strategies once SAM has developed, and does
not propose a method of preventing it.
In our study, we show that E2E can safely be used as a sur-
gical strategy to treat or prevent SAM, avoiding more com-
plicated alternatives such as annuloplasty ring removal,
downsizing, or anterior leaflet height shortening or neochor-
dae. The risk of redeveloping late SAM despite the E2E
within this patient population tended to be increased in pa-
tients with SAM diagnosed after repair. No patients devel-
oped significant stenosis secondary to the E2E repair.
There were no technical failures of the E2E repair, which
we attribute to using a multifilament, braided suture in a fig-
ure of 8 pattern, and not a monofilament.
Of patients who underwent myxomatous mitral valve re-
pair, 5.7% were either found to have SAM after repair or
were considered to be at high risk of SAM based on our pre-
diction model. This rate is consistent with those reported
previously in the literature, estimating between 7% and
11%.6,7 However, by applying our preventive E2E based
on prebypass SAM prediction, the actual rate of SAM
postrepair was decreased to 1% (12 of 1148 procedures).
This is the largest study that looks specifically at E2E for
management of SAM. Gillinov and colleagues12 first de-
scribed using this technique in a single patient with a struc-
turally normal MV with 3þmitral regurgitation and SAM
after aortic root replacement. Mascagni and colleagues13
described using this technique to prevent postrepair SAM
in 4 patients. We previously reported our early results in
20 patients.3 This study expands on these prior reports, pro-
viding longer follow-up, a larger patient population, and for
the first time shows a not insignificant risk of recurrence of
SAM despite E2E.
Our study is subject to all the limitations of a single-
institution, retrospective study. Findings from the series
may not be generalizable to other populations. Because
this was not a randomized study, we could not control for
all differences in the patient groups. Although this is a rela-
tively large series of patients for these criteria, the number
of patients in our study limits our ability to evaluate risk
factors or to match cases to better control for differences be-
tween the 2 cohorts. The annuloplasty ring was significantly
larger in the SAM prevention group, which potentially
could reduce the risk of postrepair SAM independently of
the E2E stitch, and confound the comparison between
groups. In addition, patients received their surgeries across
a 10-year span; clinical practice, patient characteristics, and
comorbidities changed over time. Outcomes for remote840 The Journal of Thoracic and Cardiovascular Surgcases may lack generalizability to future patient popula-
tions. Assessing the accuracy of our SAM prediction model
is beyond the scope of our study, and only the echocardio-
grams of patients having had an E2E for SAMmanagement
were reviewed. Furthermore, follow-up was limited to the
patients with E2E for SAM, not the entire cohort of 1148
myxomatous MV repair patients, and could potentially
miss late-onset SAM in patients who did not require surgi-
cal management.
CONCLUSIONS
E2E can safely be used as a surgical strategy to treat or
prevent SAM. The strategy is based on an expectation
that it is possible to predict SAM, resulting a much-
reduced prevalence of SAM compared with the norm
when these predictions are combined with modifications
of the surgical approach. Our study demonstrates that a pre-
emptive, single-pump-run solution to the SAM problem is
possible. The next steps will be to validate and optimize
the SAM prediction methodology, and to continue to evolve
the surgical modifications.
References
1. Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove DM. Mechanism of
outflow tract obstruction causing failed mitral valve repair. Anterior displace-
ment of leaflet coaptation. Circulation. 1993;88(5 Pt 2):II24-9.
2. Carpentier A. Cardiac valve surgery—the ‘‘French correction’’ J Thorac Cardi-
ovasc Surg. 1983;86:323-37.
3. Brinster DR, Unic D, D’Ambra MN, Nathan N, Cohn LH. Midterm results of the
edge-to-edge technique for complex mitral valve repair. Ann Thorac Surg. 2006;
81:1612-7.
4. Cevasco M, Myers PO, Elbardissi AW, Cohn LH. Foldoplasty: a new and simpli-
fied technique for mitral valve repair that produces excellent medium-term out-
comes. Ann Thorac Surg. 2011;92:1634-7; discussion, 7-8.
5. Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA. Echocardio-
graphic predictors of left ventricular outflow tract obstruction and systolic ante-
rior motion of the mitral valve after mitral valve reconstruction for myxomatous
valve disease. J Am Coll Cardiol. 1999;34:2096-104.
6. BrownML, Abel MD, Click RL, Morford RG, Dearani JA, Sundt TM, et al. Sys-
tolic anterior motion after mitral valve repair: is surgical intervention necessary?
J Thorac Cardiovasc Surg. 2007;133:136-43.
7. Freeman WK, Schaff HV, Khandheria BK, Oh JK, Orszulak TA, Abel MD, et al.
Intraoperative evaluation of mitral valve regurgitation and repair by transesopha-
geal echocardiography: incidence and significance of systolic anterior motion.
J Am Coll Cardiol. 1992;20:599-609.
8. Jebara VA, Mihaileanu S, Acar C, Brizard C, Grare P, Latremouille C, et al. Left
ventricular outflow tract obstruction after mitral valve repair. Results of the slid-
ing leaflet technique. Circulation. 1993;88(5 Pt 2):II30-4.
9. Grossi EA, Steinberg BM, LeBoutillier M 3rd, Ribacove G, Spencer FC,
Galloway AC, et al. Decreasing incidence of systolic anterior motion after mitral
valve reconstruction. Circulation. 1994;90(5 Pt 2):II195-7.
10. Sternik L, Zehr KJ. Systolic anterior motion of the mitral valve after mitral valve
repair: a method of prevention. Tex Heart Inst J. 2005;32:47-9.
11. Varghese R, Anyanwu AC, Itagaki S, Milla F, Castillo J, Adams DH. Manage-
ment of systolic anterior motion after mitral valve repair: an algorithm. J Thorac
Cardiovasc Surg. 2012;143(4 Suppl):S2-7.
12. Gillinov AM, Smedira NG, Shiota T. Use of the Alfieri edge-to-edge technique to
eliminate left ventricular outflow tract obstruction caused by mitral systolic an-
terior motion. Ann Thorac Surg. 2004;78:e92-3.
13. Mascagni R, Al Attar N, Lamarra M, Calvi S, Tripodi A, Mebazaa A, et al. Edge-
to-edge technique to treat post-mitral valve repair systolic anterior motion and
left ventricular outflow tract obstruction. Ann Thorac Surg. 2005;79:471-3;
discussion, 4.ery c October 2013
